GHRS (GH Research PLC) Stock Financials & Earnings | Market Cap Arena

GHRS (GH Research PLC) Stock Financials & Earnings | Market Cap Arena

GHRSGH Research PLC

Mkt Cap$1B

Healthcare·Biotechnology·🇮🇪 Ireland·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$48M

EPS (TTM)-$0.80

Free Cash Flow (TTM)-$44M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$10M
Q2 23	$0	$0	-$10M
Q3 23	$0	$0	-$10M
Q4 23	$0	$0	-$11M
Q1 24	$0	$0	-$12M
Q2 24	$0	$0	-$13M
Q3 24	$0	$0	-$13M
Q4 24	$0	$0	-$13M
Q1 25	$0	$0	-$13M
Q2 25	$0	$0	-$15M
Q3 25	$0	-$89K	-$17M
Q4 25	$0	-$88K	-$17M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$7M	-$7M
Q2 23	-$8M	-$8M
Q3 23	-$10M	-$10M
Q4 23	-$8M	-$8M
Q1 24	-$10M	-$10M
Q2 24	-$10M	-$10M
Q3 24	-$12M	-$12M
Q4 24	-$10M	-$10M
Q1 25	-$9M	-$9M
Q2 25	-$9M	-$9M
Q3 25	-$14M	-$14M
Q4 25	-$12M	-$12M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$22K
Q2 23	$46K
Q3 23	$8K
Q4 23	$24K
Q1 24	$12K
Q2 24	$8K
Q3 24	$4K
Q4 24	$25K
Q1 25	$4K
Q2 25	$59K
Q3 25	$41K
Q4 25	$18K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+30.1%
Q2 23	—	+47.0%
Q3 23	—	+46.7%
Q4 23	—	+21.7%
Q1 24	—	+10.6%
Q2 24	—	+33.2%
Q3 24	—	+29.9%
Q4 24	—	+16.0%
Q1 25	—	+10.4%
Q2 25	—	+11.2%
Q3 25	—	+31.0%
Q4 25	—	+29.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$551K	—
Q2 23	$451K	—
Q3 23	$647K	—
Q4 23	$591K	—
Q1 24	$300K	—
Q2 24	$108K	—
Q3 24	$273K	—
Q4 24	$759K	—
Q1 25	$2M	—
Q2 25	$2M	—
Q3 25	$0	—
Q4 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$7M	$3M	—
Q2 23	$7M	$3M	—
Q3 23	$7M	$3M	—
Q4 23	$8M	$3M	—
Q1 24	$9M	$3M	—
Q2 24	$10M	$3M	—
Q3 24	$8M	$4M	—
Q4 24	$8M	$5M	—
Q1 25	$8M	$5M	—
Q2 25	$9M	$6M	—
Q3 25	$11M	—	$6M
Q4 25	$11M	—	$5M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$105M	$58M	$163M
Q2 23	$97M	$68M	$165M
Q3 23	$86M	$75M	$161M
Q4 23	$78M	$83M	$162M
Q1 24	$77M	$80M	$158M
Q2 24	$87M	$64M	$151M
Q3 24	$90M	$60M	$150M
Q4 24	$101M	$49M	$149M
Q1 25	$245M	$46M	$291M
Q2 25	$254M	$38M	$292M
Q3 25	$250M	$39M	$289M
Q4 25	$246M	$34M	$281M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	52M	+0.0%
Q2 23	52M	+0.0%
Q3 23	52M	+0.0%
Q4 23	52M	+0.0%
Q1 24	52M	+0.0%
Q2 24	52M	+0.0%
Q3 24	52M	+0.0%
Q4 24	52M	+0.0%
Q1 25	58M	+11.5%
Q2 25	62M	+6.9%
Q3 25	62M	+0.0%
Q4 25	62M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	$0	14
FY 22	$0	32
FY 23	$0	49
FY 24	$0	50
FY 25	$0	73